NCT00332384View on ClinicalTrials.gov

Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

573

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

November 30, 2001

Study Completion Date

November 30, 2001

Conditions
Ocular Hypertension
Interventions
DRUG

brimonidine/timolol fixed combination

Trial Locations (1)

Unknown

Newport Beach

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY